Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New medicines at risk from biodiversity loss

17.10.2003


Science study reveals that habitat loss imperil one of the world’s most promising source of new drugs



In a letter published in the October 17th issue of Science, three scientists warn that biodiversity loss could have devastating consequences for drug discovery and the development of new medicines. "Tropical cone snails may contain the largest and most clinically important pharmacopoeia of any genus in Nature" says lead author of the study, Eric Chivian from the Harvard Medical School, "but wild populations are being decimated by habitat destruction and overexploitation. To lose these species would be a self-destructive act of unparalleled folly."

Approximately 500 species of cone snails inhabit shallow tropical seas. They defend themselves and paralyze their prey – worms, fish, and other molluscs – by injecting a cocktail of toxins through a hollow, harpoon-like tooth. Each species has its own distinct set of around 100 ’conotoxins’, which like a gourmet chef it mixes in constantly changing proportions, thereby preventing evolution of resistance in their prey. Co-researcher Aaron Bernstein, also of Harvard, says "To date, only about 100 of the estimated 50,000 cone snail toxins have been characterized, and only a handful tested for pharmacologic activity. The results have extraordinary promise for the development of powerful new drugs."


With more than 2600 studies published in the last 20 years, there is much excitement about conotoxins in biomedicine. "Most conotoxins are a succinct ten to forty amino acids in length and are exquisitely selective about their receptor binding sites. This makes them powerful tools for understanding how cells work and a rich source for discovery of new medicines", said Bernstein. Among many discoveries, conotoxins that block key neurological pathways have been effective in the early detection and may also help treat small-cell lung cancer, one of the most devastating human cancers. A compound now in clinical trials has powerful anti-epileptic activity. Experiments suggest that conotoxins could treat muscle spasticity following spinal cord injury. They could prevent cell death when there is inadequate circulation, such as during strokes, head injuries or coronary bypass surgery. They could also be used to treat clinical depression, heart arrhythmias and urinary incontinence.

Conotoxin research has advanced farthest in treatment of pain. The synthetic drug Prialt is in extended Stage III clinical trials for the treatment of intractable pain (unremitting, severe, and essentially untreatable pain) and could soon be on the market. "Prialt may be 1000 times more potent than morphine. More importantly, it does not seem to lead to addiction or tolerance, where increasing doses are required to achieve the same effect" said Chivian. These problems have greatly limited the long-term effectiveness of the current mainstays of severe pain therapy, morphine and other opiates. Many millions of people suffer from intractable pain and have developed tolerance to opiates, so a potent painkiller like Prialt could represent an enormous therapeutic breakthrough.

Just as we are appreciating the remarkable potential of cone snails as a source of new medicines, they are coming under intense pressure in the wild. Their shallow tropical habitats are rapidly being destroyed and snails are being collected at alarming rates from the wild to supply the ornamental shell trade as well as for biomedical research.

Cone snails are exquisitely beautiful and have been coveted by collectors since at least the 16th Century. A rare cone snail shell was sold at an Amsterdam auction in 1796 for more than a Vermeer painting! Collectors still cherish these shells, and rates of capture from the wild are escalating rapidly. "Millions of cone snails are now sold annually for as little as a few cents each in shops all over the world. But we could not find any country that monitors this trade" said co-author Callum Roberts, of the University of York, "Nobody is looking out for them."

Alongside overexploitation, cone snail habitats are being degraded and destroyed by coastal development, overfishing, pollution, disease and global climate change. A quarter of the planet’s coral reefs have already been seriously damaged or destroyed and half of the world’s mangroves cleared. The risk of global extinction is highest for species with narrow geographic distributions. The study found that one in five cone snail species had global ranges encompassing less than 3500km2 of reef, equivalent to a single medium sized atoll. For example, eight species are unique to the Philippines, the hub of the world’s ornamental shell trade. People threaten 97% of Philippine coral reefs and extinctions are inevitable if impacts are not alleviated soon.

Habitat loss and escalating, uncontrolled exploitation make a lethal combination that today threatens with extinction cone snails and many other species of biomedical interest. "International markets can develop rapidly in the modern world, which means that wild populations can be decimated before regulatory agencies see any need to protect them." said Roberts. "For this reason, we believe all internationally traded organisms (whether alive or dead) must be monitored, regardless of whether they are currently listed as threatened. This would allow countries to identify emerging markets and act early enough to prevent depletion." This could be achieved, say the authors, by extending CITES (The Convention on International Trade in Endangered Species) to cover all wild-caught species. Meanwhile, at the earliest opportunity cone snails should be added to Appendix II of CITES, so requiring countries to monitor trade and prevent overexploitation.

"Wild nature has been the template for most of the medicines we use today but we have barely even begun to tap its potential", said Chivian, "If we fail to protect cone snails, the loss to future generations would be incalculable."


For More Information Contact:

Kathleen Frith, Director of Communications, HMS Center for Health and the Global Environment, Harvard Medical School, Boston, USA. Tel: 617-384-8591, kfrith@hms.harvard.edu

Callum Roberts, Professor of Marine Conservation, University of York, UK. Tel: 44-190-443-4066, Mobile 44-772-936-9303, email: cr10@york.ac.uk.

Kathleen Frith | EurekAlert!

More articles from Ecology, The Environment and Conservation:

nachricht Preservation of floodplains is flood protection
27.09.2017 | Technische Universität München

nachricht Conservationists are sounding the alarm: parrots much more threatened than assumed
15.09.2017 | Justus-Liebig-Universität Gießen

All articles from Ecology, The Environment and Conservation >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Salmonella as a tumour medication

HZI researchers developed a bacterial strain that can be used in cancer therapy

Salmonellae are dangerous pathogens that enter the body via contaminated food and can cause severe infections. But these bacteria are also known to target...

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

3rd Symposium on Driving Simulation

23.10.2017 | Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

 
Latest News

Microfluidics probe 'cholesterol' of the oil industry

23.10.2017 | Life Sciences

Gamma rays will reach beyond the limits of light

23.10.2017 | Physics and Astronomy

The end of pneumonia? New vaccine offers hope

23.10.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>